127 related articles for article (PubMed ID: 34931430)
1. Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1/Nrf2 signaling.
Xu E; Yin C; Yi X; Liu Y
Environ Toxicol; 2022 Apr; 37(4):765-775. PubMed ID: 34931430
[TBL] [Abstract][Full Text] [Related]
2. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circADAM9 Promotes Inflammation, Oxidative Stress, and Fibrosis of Human Mesangial Cells via the Keap1-Nrf2 Pathway in Diabetic Nephropathy.
Zheng H; Liu X; Song B
Exp Clin Endocrinol Diabetes; 2023 Sep; 131(9):491-499. PubMed ID: 37463596
[TBL] [Abstract][Full Text] [Related]
4. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway.
Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R
Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942
[TBL] [Abstract][Full Text] [Related]
5. Decreasing REDD1 expression protects against high glucose-induced apoptosis, oxidative stress and inflammatory injury in podocytes through regulation of the AKT/GSK-3β/Nrf2 pathway.
Wang X; Yang J; Wang W; Li Y; Yang Y
Immunopharmacol Immunotoxicol; 2023 Oct; 45(5):527-538. PubMed ID: 36883011
[TBL] [Abstract][Full Text] [Related]
6. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling.
Zuo H; Wang S; Feng J; Liu X
Biochimie; 2019 Oct; 165():100-107. PubMed ID: 31325480
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of BRD7 protects podocytes against high glucose-induced apoptosis by enhancing Nrf2 in a GSK-3β-dependent manner.
Yu X; Jiang N; Li J; Li X; He S
Tissue Cell; 2022 Jun; 76():101813. PubMed ID: 35550209
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of SETD6 protects podocyte against high glucose and palmitic acid-induced apoptosis, and mitochondrial dysfunction via activating Nrf2-Keap1 signaling pathway in diabetic nephropathy.
Wang X; Liu Q; Kong D; Long Z; Guo Y; Wang S; Liu R; Hai C
J Mol Histol; 2020 Oct; 51(5):549-558. PubMed ID: 32803470
[TBL] [Abstract][Full Text] [Related]
9. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β.
Shen Y; Chen S; Zhao Y
Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950
[TBL] [Abstract][Full Text] [Related]
10. USP15 participates in DBP-induced testicular oxidative stress injury through regulating the Keap1/Nrf2 signaling pathway.
Zhang L; Gao X; Qin Z; Shi X; Xu K; Wang S; Tang M; Wang W; Gao S; Zuo L; Zhang L; Zhang W
Sci Total Environ; 2021 Aug; 783():146898. PubMed ID: 34088152
[TBL] [Abstract][Full Text] [Related]
11. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
[TBL] [Abstract][Full Text] [Related]
12. Mitoquinone Protects Podocytes from Angiotensin II-Induced Mitochondrial Dysfunction and Injury via the Keap1-Nrf2 Signaling Pathway.
Zhu Z; Liang W; Chen Z; Hu J; Feng J; Cao Y; Ma Y; Ding G
Oxid Med Cell Longev; 2021; 2021():1394486. PubMed ID: 34426758
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl-peptidase 3 protects oxygen-glucose deprivation/reoxygenation-injured hippocampal neurons by suppressing apoptosis, oxidative stress and inflammation via modulation of Keap1/Nrf2 signaling.
Ren X; Yu J; Guo L; Ma H
Int Immunopharmacol; 2021 Jul; 96():107595. PubMed ID: 33812256
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.
Shen Q; Fang J; Guo H; Su X; Zhu B; Yao X; Wang Y; Cao A; Wang H; Wang L
Free Radic Biol Med; 2023 Jul; 203():45-57. PubMed ID: 37030337
[TBL] [Abstract][Full Text] [Related]
15. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
[TBL] [Abstract][Full Text] [Related]
16. Keap1-Nrf2 signaling activation by Bardoxolone-methyl ameliorates high glucose-induced oxidative injury in human umbilical vein endothelial cells.
Yang JL; Sun MY; Yuan Q; Tang S; Dong MJ; Zhang RD; Liu YY; Mao L
Aging (Albany NY); 2020 Jun; 12(11):10370-10380. PubMed ID: 32484788
[TBL] [Abstract][Full Text] [Related]
17. Keap1 inhibition attenuates glomerulosclerosis.
Miyazaki Y; Shimizu A; Pastan I; Taguchi K; Naganuma E; Suzuki T; Hosoya T; Yokoo T; Saito A; Miyata T; Yamamoto M; Matsusaka T
Nephrol Dial Transplant; 2014 Apr; 29(4):783-91. PubMed ID: 24523358
[TBL] [Abstract][Full Text] [Related]
18. The Nrf2 activator MIND4-17 protects retinal ganglion cells from high glucose-induced oxidative injury.
Chen N; Li Y; Huang N; Yao J; Luo WF; Jiang Q
J Cell Physiol; 2020 Oct; 235(10):7204-7213. PubMed ID: 32020639
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.
Niederkorn M; Ishikawa C; M Hueneman K; Bartram J; Stepanchick E; R Bennett J; E Culver-Cochran A; Bolanos LC; Uible E; Choi K; Wunderlich M; Perentesis JP; M Chlon T; Filippi MD; Starczynowski DT
Leukemia; 2022 Feb; 36(2):438-451. PubMed ID: 34465865
[TBL] [Abstract][Full Text] [Related]
20. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
Zhang Q; Hu Y; Hu JE; Zhang M
Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
